Stay updated with breaking news from Director Mark Mcdade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages that have issued a report on the stock […]
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have earned a consensus rating of “Buy” from the six brokerages that are covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have issued ratings on the stock in the […]
Tourmaline Bio (NASDAQ:TRML – Get Free Report)‘s stock had its “buy” rating restated by Truist Financial in a report issued on Monday, Benzinga reports. They currently have a $74.00 price target on the stock. Truist Financial’s target price would indicate a potential upside of 209.88% from the stock’s current price. Several other equities analysts have […]
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) traded down 7.8% during trading on Tuesday . The stock traded as low as $38.61 and last traded at $39.33. 64,967 shares were traded during mid-day trading, a decline of 73% from the average session volume of 238,561 shares. The stock had previously closed at […]